Form 4: Inari Medical Director Jonathan Root Reports Stock Transaction

Director Jonathan Root of Inari Medical, Inc. reports acquisition of restricted stock units and updates beneficial ownership.

Summary

• On April 24, 2024, Jonathan Root, a director at Inari Medical, Inc., acquired 4,126 shares of common stock in the form of restricted stock units at a price of $42.41 per share.
• These restricted stock units vest in full on the earlier of the day prior to the Issuer's next annual meeting of stockholders or one year from the date of grant.
• Following this transaction, Root's directly owned common stock holdings decreased to 541,149 shares, and his spouse directly owns 335 shares.
• The transaction was reported on April 26, 2024.

Sentiment

Score: 5

Explanation: This is a neutral report of a stock transaction. It doesn't inherently indicate positive or negative sentiment.

Future Outlook

The restricted stock units vest in full on the earlier of the day prior to the Issuer's next annual meeting of stockholders or one year from the date of grant.

Industry Context

This is a routine disclosure of stock transactions by a company insider, which is common for publicly traded companies. It provides transparency to investors regarding the holdings and transactions of key personnel.

Stakeholder Impact

• The transaction provides transparency to shareholders regarding insider activity.

Key Dates